Tres Cantos Open Lab Foundation
WEBThe Tres Cantos Open Lab Foundation (TCOLF), created in 2010, allows independent researchers to access GSK R&D facilities, resources and expertise to help them advance their own research focused on medicines for endemic infectious diseases.
GSK and Tres Cantos Open Lab Foundation announce additional …
WEBSep 21, 2018 · GSK and the Tres Cantos Open Lab Foundation today announced an additional £5m in GSK funding to support the Foundation’s research and development programmes in diseases of the developing world. This new funding builds on the £10m GSK has already committed since the Foundation was created in 2010.
R&D locations - GSK
WEBGSK Jurong is a mixed Global Supply Chain and R&D site. It features clinical and development small molecule manufacturing. Our Tres Cantos site, where medicines have been discovered and developed for over 25 years, is focused on discovering new therapeutics to prevent infectious diseases.
GSK’s Tres Cantos Open Lab for R&D for Diseases of the Developing World
WEBGSK’s Tres Cantos Open Lab for R&D for Diseases of the Developing World. Providing a critical mass of knowledge around neglected diseases, to lead to the discovery and development of desperately-needed new medicines, creating a truly world-leading facility in collaborative research.
Using our science for global health - GSK
WEBTres Cantos, pharmaceutical R&D. In Tres Cantos, our scientists are working on potential new medicines for tuberculosis (TB), malaria, Neglected Tropical Diseases including Chagas disease, and causes of childhood diarrhoea and sepsis.
Tres Cantos Open Lab: celebrating a decade of innovation in ...
WEBSep 1, 2021 · The Tres Cantos Open Lab is a collaborative initiative established by GlaxoSmithKline (GSK) in 2010 to accelerate drug discovery in endemic infectious diseases via an innovative...
Tres Cantos Open Lab Foundation
WEBTres Cantos Open Lab Foundation. Open access and available facilities. The Tres Cantos site in Spain is home to GSK Global Health R&D research facility, which is focused on discovering and developing new medicines for . endemic infectious diseases.
Tres Cantos Open Lab Foundation
WEBGSK-Tres Cantos has a wide experience in parasitology and development of animal models for drug discovery purposes in which they have focused mainly in the translation of PK-PD predictions from animals to humans.
Surmounting structural barriers to tackle endemic infectious …
WEBAug 19, 2021 · The Open Lab is an experimental collaborative initiative centered at GSK’s Tres Cantos R&D Campus in Spain, offering researchers in endemic infectious diseases access to GSK’s core capabilities and expertise in drug discovery (Tres Cantos Open Lab Foundation, 2019b).
TCOLF - Tres Cantos Open Lab Foundation | LinkedIn
WEBThe Tres Cantos Open Lab Foundation (TCOLF) support research into endemic parasitic diseases by providing an opportunity for scientists from leading international institutions to work at the...